PCSK9 and familial hypercholesterolemia: For example, high cholesterol levels stimulate the expression of PCSK9, leading to the degradation of LDLR and an increase in cholesterol levels in plasma, a mechanism that is particularly evident in familial hypercholesterolemia (FH).